Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sefinew Molla"'
Publikováno v:
Medical Oncology. 38
Cancer progression requires certain tumorigenic mutations in genes encoding for different cellular and nuclear proteins. Altered expressions of these mutated genes are mediated by post-translational modifications and chromatin remodeling. Chromatin r
Autor:
Chinmayee Sethy, Sefinew Molla, Deepika Nayak, Subhajit Chatterjee, Satya Narayan, Rajalaxmi Pradhan, Michael D. Wyatt, Kunal Goutam, Niranjan Rout, Chanakya Nath Kundu
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 146:245-259
In the present study, we have systematically examined the clinical significance of Nectin-4 (encoded by the PVRL-4 gene), a marker for breast cancer stem cells (CSCs), in cancer metastasis and angiogenesis using a variety of human specimens, includin
Publikováno v:
DNA repair. 105
Apart from inducing catalytic inhibition of PARP-1, PARP inhibitors can also trap PARP proteins at the sites of DNA damage and forming toxic PARP-DNA complexes. These complexes obstruct the DNA repair process, resulting in cancer cell death. To study
Autor:
Krushna Chandra Hembram, Sefinew Molla, Chanakya Nath Kundu, Subhajit Chatterjee, Chinmayee Sethy, Deepika Nayak, Rajalaxmi Pradhan
Publikováno v:
Pathology oncology research : POR. 26(4)
Although Olaparib (Ola, a PARP-inhibitor), in combination with other chemotherapeutic agents, was clinically approved to treat prostate cancer, but cytotoxicity, off-target effects of DNA damaging agents limit its applications in clinic. To improve t
Autor:
Birendra Kumar Bindhani, Chanakya Nath Kundu, Deepika Nayak, Subhajit Chatterjee, Sefinew Molla, Chinmayee Sethy, Krushna Chandra Hembram, Rajalaxmi Pradhan
Publikováno v:
Molecular pharmaceutics. 16(7)
Using oral cancer cells ( in vitro) and in vivo xenograft mice model, we have systematically studied the detailed mechanism of anticancer activity of quinacrine-based hybrid silver (QAgNP) and gold (QAuNP) nanoparticles (NPs) and compared their effic
Autor:
Subhajit Chatterjee, Krushna Chandra Hembram, Sefinew Molla, Saptarshi Sinha, Chanakya Nath Kundu
Publikováno v:
Cellular Signalling. 80:109902
Concurrent use of DNA damaging agents with PARP inhibitors contribute to the effectiveness of the anticancer therapy. But there is a dearth of reports on the antiangiogenic effects of PARP inhibitors and the suppression of angiogenesis by this drug c
Autor:
Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy, Deepika Nayak, Rajalaxmi Pradhan, Sefinew Molla, Birendra Kumar Bindhani, Chanakya Nath Kundu
Publikováno v:
Molecular Pharmaceutics. 17:3150-3150
Autor:
Sefinew Molla
Publikováno v:
Journal of Emerging Diseases and Virology. 2
Publikováno v:
Virology Journal
Background Viral hepatitis is a life-threatening liver disease that has become important public health issue in developing countries including Ethiopia. This study was undertaken to determine the seroprevalence of HBsAgs and anti-HCV antibodies and w